Trial Summary
What is the purpose of this trial?The purpose of this open label trial is to examine the acceptability, tolerability, and feasibility and preliminary effectiveness of sleep restriction therapy for sleep problems in children with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of parent-training in delivering the intervention.
Eligibility Criteria
This trial is for children with Autism Spectrum Disorder (ASD) who are experiencing sleep problems. Parents will be trained to deliver the therapy via a secure telemedicine platform.Inclusion Criteria
Stable on medications for at least 2 weeks
Diagnosed with autism spectrum disorder based on history and review of available medical records
I have been diagnosed with sleep problems.
+2 more
Exclusion Criteria
My child currently has seizures or epilepsy.
Parent or child diagnosed with severe psychiatric disorder or unstable medical problem
Primary sleep disorder is a circadian rhythm sleep-wake disorder as determined by the sleep interview and Children's ChronoType Questionnaire.
Participant Groups
The study is testing Sleep Restriction Therapy (SRT) to see if it's acceptable, tolerable, and effective for improving sleep in children with ASD.
1Treatment groups
Experimental Treatment
Group I: Sleep Restriction TherapyExperimental Treatment1 Intervention
Participants attend telehealth sessions once per week for three weeks and implement sleep restriction therapy in between sessions and for 4 weeks during a follow-up period.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Stanford UniversityStanford, CA
Loading ...
Who Is Running the Clinical Trial?
Stanford UniversityLead Sponsor